Literature DB >> 22876444

The effects of Chinese yam-epimedium mixture on respiratory function and quality of life in patients with chronic obstructive pulmonary disease.

Ya-ling Zhao1, Hong-ru Song, Jin-xiu Fei, Ying Liang, Bing-hua Zhang, Qiu-ping Liu, Juan Wang, Ping Hu.   

Abstract

OBJECTIVE: To examine the clinical effects of a mixture of Chinese Yam and epimedium in patients with stable moderate or severe chronic obstructive pulmonary disease (COPD).
METHODS: Forty-nine patients with COPD were randomly allocated to a group whose usual treatment was supplemented with oral Chinese yam-epimedium mixture, or a control group given placebo. For each patient, body mass index, airflow obstruction, dyspnea, and exercise capacity were measured and converted into the BODE index before treatment and at one and three months after initiation of treatment. Participants also completed the St. George's respiratory questionnaire (SGRQ) at the same intervals.
RESULTS: After one month, improvements were seen in the BODE index and SGRQ of participants taking Chinese yam-epimedium mixture compared to controls. There were statistically significant differences in the SGRQ: three of its components and the total SGRQ scores were significantly decreased (P < 0.05), respiratory symptom scores had improved (P < 0.01), and the dyspnea component of the BODE index had significantly decreased (P < 0.05). Similar improvements were observed after three months of treatment, but exercise tolerance had also improved: the six-minute walking distance had significantly increased (P < 0.05) in the treatment group when compared with controls.
CONCLUSION: Chinese yam-epimedium mixture can significantly improve dyspnea, exercise capacity, and the quality of life of patients with stable moderate or severe COPD.

Entities:  

Mesh:

Year:  2012        PMID: 22876444     DOI: 10.1016/s0254-6272(13)60012-6

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  4 in total

Review 1.  The Anticancer Properties of Herba Epimedii and Its Main Bioactive Componentsicariin and Icariside II.

Authors:  Meixia Chen; Jinfeng Wu; Qingli Luo; Shuming Mo; Yubao Lyu; Ying Wei; Jingcheng Dong
Journal:  Nutrients       Date:  2016-09-13       Impact factor: 5.717

2.  Effects of icariin on cell injury and glucocorticoid resistance in BEAS-2B cells exposed to cigarette smoke extract.

Authors:  Lingli Hu; Feng Liu; Lulu Li; Li Zhang; Chen Yan; Qiuping Li; Jian Qiu; Jingcheng Dong; Jing Sun; Hongying Zhang
Journal:  Exp Ther Med       Date:  2020-04-29       Impact factor: 2.447

3.  The complete chloroplast genome of Epimedium enshiense B. L. Guo et Hsiao (Berberidaceae).

Authors:  Xiaoming Li; Tianrong Xu; Yu Yao; Qianru Yang; Chaoqun Xu; Fengmei Suo; Cheng Zhang; Guoan Shen; Baolin Guo; Xiang Liu; Shenghua Wei
Journal:  Mitochondrial DNA B Resour       Date:  2020-05-12       Impact factor: 0.658

Review 4.  Oral Chinese herbal medicine combined with pharmacotherapy for stable COPD: a systematic review of effect on BODE index and six minute walk test.

Authors:  Xiankun Chen; Brian May; Yuan Ming Di; Anthony Lin Zhang; Chuanjian Lu; Charlie Changli Xue; Lin Lin
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.